Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013762-09-001726
Filing Date
2009-09-24
Accepted
2009-09-24 14:59:27
Documents
7
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 URIGEN PHARMACEUTICALS, INC. FORM 10-K form10k.htm 10-K 4383605
2 EXHIBIT 2.1 ex211.htm EX-21.1 3719
3 EXHIBIT 23.1 ex231.htm EX-23.1 4321
4 EXHIBIT 31.1 ex311.htm EX-31.1 12840
5 EXHIBIT 31.2 ex312.htm EX-31.2 12905
6 EXHIBIT 32.1 ex321.htm EX-32.1 7331
7 EXHIBIT 32.2 ex322.htm EX-32.2 7809
  Complete submission text file 0001013762-09-001726.txt   4434149
Mailing Address 27 MAIDEN LANE, SUITE 595 SAN FRANCISCO CA 94108
Business Address 27 MAIDEN LANE, SUITE 595 SAN FRANCISCO CA 94108 (415) 781 0350
Urigen Pharmaceuticals, Inc. (Filer) CIK: 0000932352 (see all company filings)

EIN.: 943156660 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-22987 | Film No.: 091084747
SIC: 2834 Pharmaceutical Preparations